EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer

被引：252

作者：

Horn, Leora ^{[1
]}

Pao, William ^{[1
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 26期

关键词：

GROWTH-FACTOR RECEPTOR; ACTIVATING MUTATIONS; FUSION GENE; ALK KINASE; KRAS MUTATIONS; NEVER SMOKERS; PHASE-III; NPM-ALK; GEFITINIB; IDENTIFICATION;

D O I：

10.1200/JCO.2009.23.6661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4232 / 4235

页数：4

共 35 条

[1] Oncogenic mutations of ALK kinase in neuroblastoma [J].

Chen, Yuyan ;

Takita, Junko ;

Choi, Young Lim ;

Kato, Motohiro ;

Ohira, Miki ;

Sanada, Masashi ;

Wang, Lili ;

Soda, Manabu ;

Kikuchi, Akira ;

Igarashi, Takashi ;

Nakagawara, Akira ;

Hayashi, Yasuhide ;

Mano, Hiroyuki ;

Ogawa, Seishi .

NATURE, 2008, 455 (7215) :971-U56

[2] Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer [J].

Choi, Young Lim ;

Takeuchi, Kengo ;

Soda, Manabu ;

Inamura, Kentaro ;

Togashi, Yuki ;

Hatano, Satoko ;

Enomoto, Munehiro ;

Hamada, Toru ;

Haruta, Hidenori ;

Watanabe, Hideki ;

Kurashina, Kentaro ;

Hatanaka, Hisashi ;

Ueno, Toshihide ;

Takada, Shuji ;

Yamashita, Yoshihiro ;

Sugiyama, Yukihiko ;

Ishikawa, Yuichi ;

Mano, Hiroyuki .

CANCER RESEARCH, 2008, 68 (13) :4971-4976

[3] Inflammatory myofibroblastic tumor - Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases [J].

Coffin, Cheryl M. ;

Hornick, Jason L. ;

Fletcher, Christopher D. M. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (04) :509-520

[4] Somatic mutations affect key pathways in lung adenocarcinoma [J].

Ding, Li ;

Getz, Gad ;

Wheeler, David A. ;

Mardis, Elaine R. ;

McLellan, Michael D. ;

Cibulskis, Kristian ;

Sougnez, Carrie ;

Greulich, Heidi ;

Muzny, Donna M. ;

Morgan, Margaret B. ;

Fulton, Lucinda ;

Fulton, Robert S. ;

Zhang, Qunyuan ;

Wendl, Michael C. ;

Lawrence, Michael S. ;

Larson, David E. ;

Chen, Ken ;

Dooling, David J. ;

Sabo, Aniko ;

Hawes, Alicia C. ;

Shen, Hua ;

Jhangiani, Shalini N. ;

Lewis, Lora R. ;

Hall, Otis ;

Zhu, Yiming ;

Mathew, Tittu ;

Ren, Yanru ;

Yao, Jiqiang ;

Scherer, Steven E. ;

Clerc, Kerstin ;

Metcalf, Ginger A. ;

Ng, Brian ;

Milosavljevic, Aleksandar ;

Gonzalez-Garay, Manuel L. ;

Osborne, John R. ;

Meyer, Rick ;

Shi, Xiaoqi ;

Tang, Yuzhu ;

Koboldt, Daniel C. ;

Lin, Ling ;

Abbott, Rachel ;

Miner, Tracie L. ;

Pohl, Craig ;

Fewell, Ginger ;

Haipek, Carrie ;

Schmidt, Heather ;

Dunford-Shore, Brian H. ;

Kraja, Aldi ;

Crosby, Seth D. ;

Sawyer, Christopher S. .

NATURE, 2008, 455 (7216) :1069-1075

[5] Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].

Eberhard, DA ;

Johnson, BE ;

Amler, LC ;

Goddard, AD ;

Heldens, SL ;

Herbst, RS ;

Ince, WL ;

Jänne, PA ;

Januario, T ;

Johnson, DH ;

Klein, P ;

Miller, VA ;

Ostland, MA ;

Ramies, DA ;

Sebisanovic, D ;

Stinson, JA ;

Zhang, YR ;

Seshagiri, S ;

Hillan, KJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909

[6] EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers [J].

Fukuyoshi, Y. ;

Inoue, H. ;

Kita, Y. ;

Utsunomiya, T. ;

Ishida, T. ;

Mori, M. .

BRITISH JOURNAL OF CANCER, 2008, 98 (09) :1536-1539

[7] Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK [J].

Galkin, Anna V. ;

Melnick, Jonathan S. ;

Kim, Sungjoon ;

Hood, Tami L. ;

Li, Nanxin ;

Li, Lintong ;

Xia, Gang ;

Steensma, Ruo ;

Chopiuk, Greg ;

Jiang, Jiqing ;

Wan, Yongqin ;

Ding, Peter ;

Liu, Yi ;

Sun, Fangxian ;

Schultz, Peter G. ;

Gray, Nathanael S. ;

Warmuth, Markus .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :270-275

[8] Activating mutations in ALK provide a therapeutic target in neuroblastoma [J].

George, Rani E. ;

Sanda, Takaomi ;

Hanna, Megan ;

Frohling, Stefan ;

Luther, William, II ;

Zhang, Jianming ;

Ahn, Yebin ;

Zhou, Wenjun ;

London, Wendy B. ;

McGrady, Patrick ;

Xue, Liquan ;

Zozulya, Sergey ;

Gregor, Vlad E. ;

Webb, Thomas R. ;

Gray, Nathanael S. ;

Gilliland, D. Gary ;

Diller, Lisa ;

Greulich, Heidi ;

Morris, Stephan W. ;

Meyerson, Matthew ;

Look, A. Thomas .

NATURE, 2008, 455 (7215) :975-978

[9] EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers [J].

Inamura, Kentaro ;

Takeuchi, Kengo ;

Togashi, Yuki ;

Nomura, Kimie ;

Ninomiya, Hironori ;

Okui, Michiyo ;

Satoh, Yukitoshi ;

Okumura, Sakae ;

Nakagawa, Ken ;

Soda, Manabu ;

Choi, Young Lim ;

Niki, Toshiro ;

Mano, Hiroyuki ;

Ishikawa, Yuichi .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :13-17

[10] EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset [J].

Inamura, Kentaro ;

Takeuchi, Kengo ;

Togashi, Yuki ;

Hatano, Satoko ;

Ninomiya, Hironori ;

Motoi, Noriko ;

Mun, Ming-yon ;

Sakao, Yukinori ;

Okumura, Sakae ;

Nakagawa, Ken ;

Soda, Manabu ;

Choi, Young Lim ;

Mano, Hiroyuki ;

Ishikawa, Yuichi .

MODERN PATHOLOGY, 2009, 22 (04) :508-515

← 1 2 3 4 →